Secretory Leukocyte Protease Inhibitor (SLPI)

Characterization of human sporadic ALS biomarkers in the familial ALS transgenic mSOD1G93A mouse model

(2013) Eitan Lilo et al.   HUMAN MOLECULAR GENETICS

Secretory Leukocyte Protease Inhibitor Reverses Inhibition by CNS Myelin, Promotes Regeneration in the Optic Nerve, and Suppresses Expression of the Transforming Growth Factor-  Signaling Protein Smad2

(2013) S. S. Hannila et al.   JOURNAL OF NEUROSCIENCE

Secretory Leukocyte Protease Inhibitor Binds to Neisseria gonorrhoeae Outer Membrane Opacity Protein and is Bactericidal

(2012) Morris D. Cooper et al.   AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY

War and peace between WAP and HIV: role of SLPI, trappin-2, elafin and ps20 in susceptibility to HIV infection

(2012) Anna G. Drannik et al.   BIOCHEMICAL SOCIETY TRANSACTIONS

Beneficial effects of secretory leukocyte protease inhibitor after spinal cord injury

(2010) Nader Ghasemlou et al.   BRAIN

The Phospholipid Scramblases 1 and 4 Are Cellular Receptors for the Secretory Leukocyte Protease Inhibitor and Interact with CD4 at the Plasma Membrane

(2009) Bénédicte Py et al.   PLoS One

Secretory Leukocyte Protease Inhibitor

(2008) Sonia A. Gomez et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

The Effect of Secretory Leukocyte Protease Inhibitor (SLPI) on Ischemia/Reperfusion Injury in Cardiac Transplantation

(2008) S. Schneeberger et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Novel role for SLPI in MOG-induced EAE revealed by spinal cord expression analysis

(2008) Andre M Mueller et al.   Journal of Neuroinflammation

TGF -Smad2 Signaling Regulates the Cdh1-APC/SnoN Pathway of Axonal Morphogenesis

(2008) J. Stegmuller et al.   JOURNAL OF NEUROSCIENCE